Initial treatments using the brand new PROTEUS device were executed in leading world centers.

Angioslide introduces new 5x300mm PROTEUS gadget for treating Superficial Femoral Artery Angioslide Ltd nolvadex-uk.com/how-to-treat-gyno-with-tamoxifen http://nolvadex-uk.com . Announces the first procedures with its new 5x300mm PROTEUS gadget for treating the Superficial Femoral Artery . The new 5×300 mm size joins Angioslide’s current dedicated product line solutions for the lower limbs. Initial treatments using the brand new PROTEUS device were executed in leading world centers, Parkkrankenhaus Leipzig and Herzzentrum Bad Krozingen, located in Germany. The PROTEUS 5X300 mm can help you treat lesions up to 300 mm with one device, while providing an immediate solution for embolic catch. Angioslide’s breakthrough technology, now available also in 300 mm length aswell, is a unique alternative for lesions with high level of embolic material, including Chronic Total Occlusions , in stent-restenosis, thrombus comprising lesions and post atherectomy PTA, said Prof.

pct

Animal research displays promise in treating AD, brain damage and heart problems resulting from SCIs New animal studies provide extra support for investigating stem cell remedies for Parkinson's disease, head trauma, and harmful heart problems that accompany spinal-cord injury, today according to analyze findings released. The ongoing function, presented at Neuroscience 2012, the annual interacting with of the Society for Neuroscience and the globe's largest way to obtain emerging news about mind health and science, shows scientists making progress toward using stem cell therapies to correct neurological damage.